Related references
Note: Only part of the references are listed.Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
Hiroaki Wakimoto et al.
NEURO-ONCOLOGY (2012)
Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas
Xue-yuan Li et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Rictor Regulates MMP-9 Activity and Invasion Through Raf-1-MEK-ERK Signaling Pathway in Glioma Cells
Gowry Das et al.
MOLECULAR CARCINOGENESIS (2011)
Oncogenic EGFR Signaling Activates an mTORC2-NF-κB Pathway That Promotes Chemotherapy Resistance
Kazuhiro Tanaka et al.
CANCER DISCOVERY (2011)
Recent Advances in Therapy for Glioblastoma
Jennifer Clarke et al.
ARCHIVES OF NEUROLOGY (2010)
Targeting SRC in glioblastoma tumors and brain metastases Rationale and preclinical studies
Manmeet S. Ahluwalia et al.
CANCER LETTERS (2010)
The PKB/AKT Pathway in Cancer
Amancio Carnero
CURRENT PHARMACEUTICAL DESIGN (2010)
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
David A. Reardon et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
Camilla Krakstad et al.
MOLECULAR CANCER (2010)
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
Jeffrey J. Raizer et al.
NEURO-ONCOLOGY (2010)
Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
W. K. Alfred Yung et al.
NEURO-ONCOLOGY (2010)
Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
C. A. Sparks et al.
ONCOGENE (2010)
Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation
Jennifer R. Molina et al.
NEOPLASIA (2010)
Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
Kimmo J. Hatanpaa et al.
NEOPLASIA (2010)
Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
Hiroaki Wakimoto et al.
CANCER RESEARCH (2009)
The Double-Edged Sword of Autophagy Modulation in Cancer
Eileen White et al.
CLINICAL CANCER RESEARCH (2009)
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)
Teri N. Kreisl et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Reduction of protein kinase C ζ inhibits migration and invasion of human glioblastoma cells
Hua Guo et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand?
Georg Karpel-Massler et al.
MOLECULAR CANCER RESEARCH (2009)
The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Jin Kyung Rho et al.
MOLECULAR CANCER RESEARCH (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead
Tiffany T. Huang et al.
NEUROTHERAPEUTICS (2009)
siRNA-Mediated Integrin-Linked Kinase Suppression: Nonspecific Effects of siRNA/Cationic Liposome Complexes Trigger Changes in the Expression of Phosphorylated-AKT and mTOR Independently of ILK Silencing
Maite Verreault et al.
OLIGONUCLEOTIDES (2009)
The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair
M-A Westhoff et al.
ONCOGENE (2009)
Oncogenic EGFR Signaling Networks in Glioma
Paul H. Huang et al.
SCIENCE SIGNALING (2009)
The postoperative brain tumour stem cell (BTSC) niche and cancer recurrence
Jian-Min Liu et al.
ADVANCES IN THERAPY (2008)
mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
Juan M. Garcia-Martinez et al.
BIOCHEMICAL JOURNAL (2008)
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling
Tsuneo Ikenoue et al.
EMBO JOURNAL (2008)
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
J. F. de Groot et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Brain Tumour Stem Cells: Implications for Cancer Therapy and Regenerative Medicine
Manuel Sanchez-Martin
CURRENT STEM CELL RESEARCH & THERAPY (2008)
mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor
Janine Masri et al.
CANCER RESEARCH (2007)
Cellular responses to EGFR inhibitors and their relevance to cancer therapy
Pinaki R. Dutta et al.
CANCER LETTERS (2007)
Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo
Esther Arwert et al.
CANCER RESEARCH (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Gefitinib in patients with progressive high-grade gliomas:: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
E. Franceschi et al.
BRITISH JOURNAL OF CANCER (2007)
Targeting malignant glioma survival signalling to improve clinical outcomes
Michael L. H. Wong et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2007)
The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications
Jean L. Nakamura
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas
M. Kelly Nicholas et al.
CLINICAL CANCER RESEARCH (2006)
Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity
Cory Allen et al.
CANCER RESEARCH (2006)
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα but not S6K1
David A. Guertin et al.
DEVELOPMENTAL CELL (2006)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-Deficient and PTEN-intact glioblastoma cells
Maria Y. Wang et al.
CANCER RESEARCH (2006)
New treatment strategies for malignant gliomas
Sith Sathornsumetee et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo
CS Kang et al.
CANCER GENE THERAPY (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model
T Arao et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival
AA Troussard et al.
CANCER RESEARCH (2006)
Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo
O Saydam et al.
MOLECULAR THERAPY (2005)
Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells
RD Rao et al.
NEOPLASIA (2005)
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun et al.
CANCER RESEARCH (2005)
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study
E Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
SM Chang et al.
INVESTIGATIONAL NEW DRUGS (2005)
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth
LA Edwards et al.
ONCOGENE (2005)
Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis
F Lefranc et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase
JH Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Cα in endothelial cells
C Partovian et al.
CELLULAR SIGNALLING (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy:: A phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
AA Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer
Y Zhang et al.
CLINICAL CANCER RESEARCH (2004)
RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival
N Shinomiya et al.
CANCER RESEARCH (2004)
Phase II trial of gefitinib in recurrent glioblastoma
JN Rich et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2
N Marcoux et al.
ONCOGENE (2003)
United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling
BD Manning et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Role of MAP kinase in tumor progression and invasion
KB Reddy et al.
CANCER AND METASTASIS REVIEWS (2003)
Protein kinase Cα (PKCα):: Regulation and biological function
S Nakashima
JOURNAL OF BIOCHEMISTRY (2002)
PCV chemotherapy for recurrent glioblastoma multiforme
AC Kappelle et al.
NEUROLOGY (2001)
Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
A Toker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
